BD Names Dr. Carrie Byington To Board Of Directors

FRANKLIN LAKES, N.J., Oct. 22, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13. Byington, 58, is executive vice president and head of University of California Health (UCH), where she... Read more

Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)

Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1 The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study. This new test expands Roche’s... Read more

Danaher Reports Third Quarter 2021 Results

WASHINGTON, Oct. 21, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the third quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended October 1, 2021, net earnings were $1.2 billion, or $1.54 per diluted common share which represents a 33.0% year-over-year increase... Read more

Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

Eppendorf AG completes conversion to European public limited company

19.10.2021 Hamburg, October 2021 • Conversion to SE (“Societas Europaea”) completed • No impact on current business• Group headquarter remains in Hamburg, Germany The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE... Read more

Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can... Read more

Xylem to Release Third Quarter 2021 Financial Results on November 2, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2021 results at 6:55 a.m. (ET) on Tuesday, November 2, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more

SPT Labtech integrates recent acquisitions into unified brand and portfolio

12/10/2021 SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, unveils new branding that brings together its technologies with those from recent acquisitions into a single entity. The merged portfolio and positioning reflect SPT Labtech’s commitment to harnessing the ingenuity and product development track record... Read more